Prot# A5481004: Phase 1/2 Open-Label Study of the Safety and Efficacy of PD 0332991 in Combination with Bortezomib and Dexamethasone in Patients with Refractory Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date9/22/08 → 9/22/11

Funding

  • INC Research, LLC (A5481004 // A5481004)
  • Pfizer Inc. (A5481004 // A5481004)